Skip to main content
Equibles

Woodline Partners LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1784547 San Francisco, CA
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$12,876,065
-$834,106 QoQ
Shares Held
700,929
0.0% QoQ
Ownership
0.619%
of shares outstanding
% of Portfolio
0.04%
of 13F equity value
Holder Rank
#43
of 215 holders
Holding Since
Dec 2021
17 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Woodline Partners LP holds $4,400,572,274 across 197 Biotechnology names. VRDN ranks #83 (0.3% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 2,002,863 $375,096,182
2 PTGX
Protagonist Therapeutics, Inc
 1,414,173 $173,349,326
3 TNGX
Tango Therapeutics, Inc.
 4,000,567 $125,057,724
4 BHVN
Biohaven Ltd.
 7,660,280 $113,984,966
5 COGT
Cogent Biosciences, Inc.
 2,603,162 $100,742,369
6 CYTK
Cytokinetics Inc
 1,100,708 $93,769,314
7 RCUS
Arcus Biosciences, Inc.
 3,007,798 $92,730,412
8 ROIV
Roivant Sciences Ltd.
 2,500,673 $88,498,817

All Filings in VRDN

Export CSV
17 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $12,876,065 700,929
2026-03-31 $13,710,171 700,929
2025-12-31 $34,727,710 1,115,929
2025-09-30 $17,598,166 815,485
2025-06-30 $11,400,480 815,485
2025-03-31 $10,967,961 813,647
2024-12-31 $15,597,612 813,647
2024-09-30 $18,632,136 818,995
2024-06-30 $5,215,904 400,915
2024-03-31 $7,685,524 438,922
2023-06-30 $3,998,147 168,060
2023-03-31 $3,038,782 119,449
2022-12-31 $9,468,100 324,139
2022-09-30 $6,068,375 295,874
2022-06-30 $6,390,932 552,371
2022-03-31 $4,091,041 221,257
2021-12-31 $5,094,135 257,670